초록
Great interest has prompted Boron Neutron Capture Therapy (BNCT) as a new treatment for brain tumors. The use of $^{252}$Cf as a neutron source for BNn makes the in-hospital treatments of tumors to be possible. Newly proposed subcritical multiplying assemblies (SMA) are explored to improve relatively tow neutron fluxes of the source and construct the feasibilities of $^{252}$Cf as a neutron source. The MCNP code has been used to evaluate the effective multiplication factor of the entire system and the intensities and percentages of epithermal neutron flux at the patient-end surface of the system. The neutron beam using SMA shows the epithermal neutron flux enhancement of about 13 times as large as the beam without using SMA. It is expected that the neutron beam proposed in this research will be more effective for treatment of tumors due to the increased therapeutic neutron fluxes.
